Hideyuki Arimitsu

764 total citations
37 papers, 597 citations indexed

About

Hideyuki Arimitsu is a scholar working on Infectious Diseases, Neurology and Endocrinology. According to data from OpenAlex, Hideyuki Arimitsu has authored 37 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 17 papers in Neurology and 15 papers in Endocrinology. Recurrent topics in Hideyuki Arimitsu's work include Botulinum Toxin and Related Neurological Disorders (17 papers), Escherichia coli research studies (14 papers) and Clostridium difficile and Clostridium perfringens research (11 papers). Hideyuki Arimitsu is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (17 papers), Escherichia coli research studies (14 papers) and Clostridium difficile and Clostridium perfringens research (11 papers). Hideyuki Arimitsu collaborates with scholars based in Japan, Australia and Netherlands. Hideyuki Arimitsu's co-authors include Keiji Oguma, Yoshihiko Sakaguchi, Tohru Ohyama, Toshihiro Watanabe, Takao Tsuji, Yukako Fujinaga, Jae‐Chul Lee, Kaoru Inoue, Kentaro Tsukamoto and Keiko Sasaki and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Journal of Bacteriology.

In The Last Decade

Hideyuki Arimitsu

36 papers receiving 568 citations

Peers

Countries citing papers authored by Hideyuki Arimitsu

Since Specialization

Citations

This map shows the geographic impact of Hideyuki Arimitsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideyuki Arimitsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideyuki Arimitsu more than expected).

Fields of papers citing papers by Hideyuki Arimitsu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideyuki Arimitsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideyuki Arimitsu. The network helps show where Hideyuki Arimitsu may publish in the future.

Co-authorship network of co-authors of Hideyuki Arimitsu

This figure shows the co-authorship network connecting the top 25 collaborators of Hideyuki Arimitsu. A scholar is included among the top collaborators of Hideyuki Arimitsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideyuki Arimitsu. Hideyuki Arimitsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Characterization of α-hemolysin-specific monoclonal antibodies for detection in the culture supernatant of pathogenic <i>Escherichia coli</i> strains 2025 ·Journal of Veterinary Medical Science ·H. Fujimoto, Satoshi Kida, Tomoko Kohda, Masafumi Mukamoto, Masahiro Kusumoto, Hideyuki Arimitsu	0
2	Development of a homogeneous time-resolved FRET (HTRF) assay for the quantification of Shiga toxin 2 produced by E. coli 2021 ·PeerJ ·Keiji Nakamura, (unknown), Hideyuki Arimitsu, Yoshiki Etoh, (unknown), (unknown), Itsuki Taniguchi, Yasuhiro Gotoh, Yoshitoshi Ogura, Tetsuya Hayashi	5
3	Luteolin suppresses 5-hydroxytryptamine elevation in stimulated RBL-2H3 cells and experimental colitis mice 2021 ·Journal of Clinical Biochemistry and Nutrition ·(unknown), Akira Murakami, Hideyuki Arimitsu, Toshiyuki Nakamura, Yoshimasa Nakamura, Yoji Kato	7
4	Simple Method for Shiga Toxin 2e Purification by Affinity Chromatography via Binding to the Divinyl Sulfone Group 2013 ·PLoS ONE ·Hideyuki Arimitsu, Keiko Sasaki, (unknown), (unknown), Takao Tsuji	8
5	P19 embryonal carcinoma cells exhibit high sensitivity to botulinum type C and D/C mosaic neurotoxins 2012 ·Microbiology and Immunology ·Kentaro Tsukamoto, Hideyuki Arimitsu, Sadayuki Ochi, Keiji Nakamura, Yoshikazu Tanaka, (unknown), Koki Taniguchi, Shunji Kozaki, Takao Tsuji	6
6	Single chain variable fragment antibodies against Shiga toxins isolated from a human antibody phage display library 2011 ·Vaccine ·P. Neri, (unknown), (unknown), Kentaro Tsukamoto, Hideyuki Arimitsu, (unknown), Yasushi Akahori, Yoshikazu Kurosawa, Takao Tsuji	14
7	Nucleotide sequence analysis of the enterotoxigenic Escherichia coli Ent plasmid 2009 ·DNA Research ·Satoshi Ochi, Tadamichi Shimizu, Kaori Ohtani, Yuki Ichinose, Hideyuki Arimitsu, Kentaro Tsukamoto, Masaya Kato, Toshio Tsuji	15
8	Lincomycin-induced over-expression of mature recombinant cholera toxin B subunit and the holotoxin in Escherichia coli 2009 ·Protein Expression and Purification ·Hideyuki Arimitsu, Kentaro Tsukamoto, Sadayuki Ochi, Keiko Sasaki, Michio Kato, Koki Taniguchi, Keiji Oguma, Takao Tsuji	10
9	A nasal vaccine comprising B-subunit derivative of Shiga toxin 2 for cross-protection against Shiga toxin types 1 and 2 2008 ·Vaccine ·Takao Tsuji, Takeshi Shimizu, Keiko Sasaki, Kentaro Tsukamoto, Hideyuki Arimitsu, Sadayuki Ochi, (unknown), Koki Taniguchi, Masatoshi Noda, P. Neri, Hiroshi Mori	22
10	Molecular properties of each subcomponent in Clostridium botulinum type B haemagglutinin complex 2008 ·Microbial Pathogenesis ·Hideyuki Arimitsu, Yoshihiko Sakaguchi, Jae‐Chul Lee, Sadayuki Ochi, Kentaro Tsukamoto, Yumiko Yamamoto, (unknown), Takao Tsuji, Keiji Oguma	16
11	Clinical application ofClostridium botulinumtype A neurotoxin purified by a simple procedure for patients with urinary incontinence caused by refractory destrusor overactivity 2007 ·FEMS Immunology & Medical Microbiology ·Jae‐Chul Lee, Teruhiko Yokoyama, Hyun-Jung Hwang, Hideyuki Arimitsu, Yumiko Yamamoto, (unknown), Tomoko Takigawa, Kouichi Takeshi, Atsushi Nishikawa, Hiromi Kumon, Keiji Oguma	19
12	Protection of mice from Shiga toxin-2 toxemia by mucosal vaccine of Shiga toxin 2B-His with Escherichia coli enterotoxin 2007 ·Vaccine ·Takao Tsuji, Takeshi Shimizu, Keiko Sasaki, (unknown), Kentaro Tsukamoto, Hideyuki Arimitsu, Sadayuki Ochi, Satoshi Sugiyama, Koki Taniguchi, P. Neri, Hiroshi Mori	12
13	Mutant Escherichia coli enterotoxin as a mucosal adjuvant induces specific Th1 responses of CD4+ and CD8+ T cells to nasal killed-bacillus calmette–guerin in mice 2006 ·Vaccine ·Hiroki Takahashi, Keiko Sasaki, Miyuki Takahashi, (unknown), (unknown), Hideyuki Arimitsu, Sadayuki Ochi, Naoya Ohara, Takao Tsuji	12
14	A mutant of Escherichia coli enterotoxin inducing a specific Thl-type of T cells to varicella-zoster vaccine enhances the production of IL-12 by IFNγ-stimulated macrophages 2005 ·Vaccine ·(unknown), Keiko Sasaki, Michio Kato, Hideyuki Arimitsu, Sadayuki Ochi, Tomomasa Yano, Keiji Oguma, Takashi Yokochi, Takao Tsuji	2
15	The receptor and transporter for internalization of Clostridium botulinum type C progenitor toxin into HT-29 cells 2004 ·Biochemical and Biophysical Research Communications ·Atsushi Nishikawa, Nobuo Uotsu, Hideyuki Arimitsu, Jae‐Chul Lee, Yutaka Miura, Yukako Fujinaga, Hiroshi Nakada, Toshihiro Watanabe, Tohru Ohyama, Yoshiyuki Sakano, Keiji Oguma	46
16	Vaccination with Recombinant Whole Heavy Chain Fragments of Clostridium botulinum Type C and D Neurotoxins 2004 ·Clinical and Vaccine Immunology ·Hideyuki Arimitsu, (unknown), Yoshihiko Sakaguchi, Yûji Hayakawa, Michiko Hayashi, (unknown), (unknown), (unknown), Masafumi Mukamoto, Tom Murphy, Keiji Oguma	21
17	Molecular characterization of binding subcomponents of Clostridium botulinum type C progenitor toxin for intestinal epithelial cells and erythrocytes 2004 ·Microbiology ·Yukako Fujinaga, Kaoru Inoue, Shinobu Watarai, Yoshihiko Sakaguchi, Hideyuki Arimitsu, (unknown), Yingji Jin, Takuhiro Matsumura, (unknown), Toshihiro Watanabe, Tohru Ohyama, Atsushi Nishikawa, Keiji Oguma	57
18	Mucosal immunisation with Clostridium botulinum type C 16 S toxoid and its non-toxic component 2002 ·Journal of Medical Microbiology ·(unknown), (unknown), Tadahiro Karasawa, (unknown), Kaoru Inoue, Yoshihiko Sakaguchi, Yukako Fujinaga, Hideyuki Arimitsu, Keiji Oguma, Tohru Ohyama, (unknown), Kenji Yokota, Robert G. Hirst, Tom Murphy, Shinichiro Nakamura	7
19	Clostridium botulinum type A haemagglutinin-positive progenitor toxin (HA+-PTX) binds to oligosaccharides containing Galβ1-4GlcNAc through one subcomponent of haemagglutinin (HA1) 2001 ·Microbiology ·Kaoru Inoue, Yukako Fujinaga, Koichi Honke, Hideyuki Arimitsu, (unknown), Yoshihiko Sakaguchi, Tohru Ohyama, Toshihiro Watanabe, Katsuhiro Inoue, Keiji Oguma	42
20	Enhancement of phagocytic and chemokinetic activities of rainbow trout head kidney cells by C-reactive protein 1999 ·American Journal of Veterinary Research ·Hiroshi Kodama, Hideyuki Arimitsu, Masafumi Mukamoto, Chihiro Sugimoto	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact